Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Szigetvar – page 29

461 clinical trials in Szigetvar, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Szigetvar at a glance
461
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

461 trials in Szigetvar

Open in trial search

Plasma cell myeloma

Not recruiting

Study of Isatuximab, Lenalidomide, and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on Long-Term Safety of Soticlestat for Patients with Dravet or Lennox-Gastaut Syndromes

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years
  • Substances:Soticlestat
  • Sponsor:Takeda Development Center Americas Inc.

Study on the Effects of RGX-314 Gene Therapy Compared to Aflibercept and Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Hypertension

Not recruiting

Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:Astrazeneca AB

Follicular lymphoma

Not recruiting

Study of Ibrutinib and Rituximab for Patients with Follicular Lymphoma

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Hidradenitis

Not recruiting

Study on Amlitelimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Octapharma Pharmazeutika Produktionsgesellschaft mbH

Hepatic cirrhosis

Not recruiting

Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Human Serum Albumin
  • Sponsor:Instituto Grifols S.A.

Cardiac failure

Not recruiting

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Novartis Pharma AG

Malignant melanoma

Not recruiting

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Asthma

Not recruiting

Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Areteia Therapeutics Inc.

Chronic kidney disease+1

Not recruiting

Study on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB

Investigational
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Szigetvar

What the registry says about research in the country

01 Respiratory Medicine

Comprehensive research focusing on severe asthma treatments, particularly in pediatric populations. Studies evaluate novel therapies including dupilumab and tezepelumab for improving respiratory function.

  • Pediatric Asthma Management
  • Severe Exacerbation Prevention
  • Respiratory Function Improvement

Multiple trials are exploring innovative approaches to control asthma symptoms in children aged 2-12 years.

02 Allergic Conditions

Investigations into allergic rhinoconjunctivitis treatments, with specific focus on birch pollen allergies. Research includes evaluation of STALORAL® Birch therapy for pediatric and adolescent patients.

  • Allergy Immunotherapy
  • Pediatric Allergy Treatment
  • Symptom Management

Studies aim to improve quality of life for young patients with seasonal allergies.

03 Cardiovascular Research

Advanced studies in heart failure prevention and cardiovascular health, including investigation of baxdrostat in combination with dapagliflozin. Additional focus on cardiovascular complications in dialysis patients.

  • Heart Failure Prevention
  • Cardiovascular Risk Management
  • ESKD-related Heart Disease

Research targets reduction of cardiovascular events and mortality in high-risk populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.